Legal Representation
Attorney
Patrick J. Jennings
USPTO Deadlines
Application History
31 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 16, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Sep 16, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Feb 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 12, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Feb 6, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 22, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jan 22, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 11, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 9, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Aug 9, 2023 | EXT4 | S | SOU EXTENSION 4 FILED |
| Aug 9, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 19, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jan 19, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jan 19, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 4, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 4, 2022 | EXT2 | S | SOU EXTENSION 2 FILED |
| Aug 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 10, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 8, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 8, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
| Feb 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 10, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jun 15, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 15, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 26, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 12, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 6, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 4, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 3, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Pharmaceutical research and development; pharmaceutical product evaluation; testing of pharmaceuticals; development of pharmaceutical preparations and medicines; and scientific research in the fields of protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, assays, benign prostatic hyperplasia, and prostate cancer
First Use Anywhere:
19951200
First Use in Commerce:
19951200
Classification
International Classes
042
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO